MyMD Pharmaceuticals Ownership | Who Owns MyMD Pharmaceuticals?
MyMD Pharmaceuticals Ownership Summary
MyMD Pharmaceuticals is owned by 0.01% institutional investors, and 99.99% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.58% of its assets in MyMD Pharmaceuticals shares.
MYMD Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | MyMD Pharmaceuticals | 0.01% | - | 99.99% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Institutional Extnd Mkt Idx Tr | 13.69K | 0.58% | - |
Fidelity Extended Market Index | 11.64K | 0.49% | 1.56K |
BlackRock Extended Equity Market K | 1.56K | 0.07% | -1.00 |
Fidelity Total Market Index | 1.55K | 0.07% | - |
Fidelity Series Total Market Index | 1.23K | 0.05% | - |
NT Ext Equity Mkt Idx Fd - NL | 1.00K | 0.04% | - |
Fidelity Nasdaq Composite Index | 905.00 | 0.04% | - |
Northern Trust Extended Eq Market Idx | 884.00 | 0.04% | - |
NT Ext Equity Mkt Idx Fd - L | 884.00 | 0.04% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 809.00 | 0.03% | 2.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 24, 2023 | Rivard Paul | Chief Legal Officer | Buy | $166.50K |
Aug 17, 2023 | Rivard Paul | Chief Legal Officer | Buy | $28.08K |
Dec 08, 2022 | Rivard Paul | EVP of Operations, GC | Buy | $15.30K |
Nov 24, 2021 | Silverman Joshua | - | Buy | $23.17K |
Nov 26, 2021 | Silverman Joshua | - | Buy | $37.77K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q3 | 2 | - |
2023 Q2 | - | - |
2022 Q4 | 1 | - |
2021 Q4 | 4 | - |
2021 Q2 | - | - |
MYMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools